Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving breathing function with digital biofeedback

Official title: Improving Outcomes in Dysfunctional Breathing Through the Optimization of Muscle Function (OptiMuscle)

Run by University of Salford · NCT06103955 · Data updated 2026-11-12

This study is testing if a digital breathing tool can help people with breathing problems improve their lung function and feel better when used alongside breathing exercises from a physiotherapist.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of Salford
Academic / other
Locations1 site (Manchester, Greater Manchester)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedMarch 31, 2027
Study endsJune 30, 2027
Registry record updatedAugust 19, 2026
Trial IDNCT06103955 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a clinical diagnosis of dysfunctional breathing who have experienced breathing difficulties for at least six months.

Probably not a fit

Patients currently receiving active treatment for dysfunctional breathing or those with significant respiratory co-morbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate whether a digital breathing biofeedback system can enhance the effectiveness of physiotherapist-guided breathing retraining for individuals with dysfunctional breathing. Approximately 10% of the UK population experiences dysfunctional breathing, which can lead to symptoms like breathlessness and dizziness. The intervention involves using a digital health system that provides real-time biofeedback on muscle patterns to help patients learn proper breathing control. Participants will undergo four sessions of breathing retraining while utilizing this system, with assessments of lung function and quality of life conducted before and after treatment.

Why it matters

Potential benefit: If successful, this approach could significantly improve breathing control and quality of life for patients with dysfunctional breathing.

How similar studies have gone: While the use of digital biofeedback in respiratory therapy is emerging, this specific approach is novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to stand and walk independently
* History of breathing difficulties, such as breathlessness and difficult or laboured breathing for at least previous 6 months.
* Clinical diagnosis of dysfunctional breathing, sometimes referred to as breathing pattern disorder.
* If participants have co-existing respiratory problems, e.g. asthma, these should not be felt (in the opinion of the referring clinician) to be the cause of the current symptoms of breathlessness.

Exclusion Criteria:

* Inability to speak and understand English sufficient to read and understand the information sheet and sign the consent form.
* BMI \>34
* Currently receiving active treatment for dysfunctional breathing
* Received treatment for acute lower respiratory tract infection or asthma exacerbation with last 4 weeks
* Significant respiratory co-morbidity (i.e. where the major respiratory diagnosis is not asthma)

Where it's running

  • University of Salford
    Manchester, Greater Manchester, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.